ヒトパピローマウイルス検査市場、規模、シェア、動向、産業分析レポート：製品別、用途別、技術別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、ヒトパピローマウイルス（HPV）検査の世界市場規模は2034年までに55億4,792万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ヒトパピローマウイルス（HPV）検査市場は、生物学的サンプル中のHPVウイルスの存在を検出するために使用される診断検査の販売と流通を包含します。特定の高リスクHPV遺伝子型への持続感染がこの疾患の主な原因であるため、主に女性の健康に利用されるこれらの検査は、子宮頸がんのスクリーニングにおいて重要な役割を果たしています。この市場には、HPV DNAまたはRNAを同定する分子検査など、さまざまな検査手法、関連機器、消耗品、検査機関やヘルスケアプロバイダーが提供する検査サービスが含まれます。

ヒトパピローマウイルス検査市場は、HPVと子宮頸がんとの関連性に対する意識の高まり、全国的な子宮頸がん検診プログラムの実施、診断技術の進歩などを背景に、大きな成長を遂げています。主要な市場促進要因は、HPV検査を一次スクリーニングツールとして、あるいは従来のHPV検査やPAP検査と併用して採用する動きが広がっていることです。さらに、より高感度で特異的なHPVアッセイの開発と自己採取オプションの導入により、市場への浸透とアクセシビリティが高まっています。市場の見通しは、進行中の調査、がんの早期発見に対する市場の需要の増加、予防ヘルスケアを推進する政府の積極的な取り組みに後押しされ、引き続き明るいです。

ヒトパピローマウイルス検査市場レポート・ハイライト

アプリケーション別では、子宮頸がん検診サブセグメントが現在世界最大の市場シェアを占めています。これは、ルーチン検診プログラムでの役割が確立されていること、前がん病変の早期発見が重視されていることによる。

製品別では、試薬、アッセイキット、その他の使い捨て材料は、スクリーニングや診断のために世界中で大量に実施されるHPV検査で繰り返し必要とされるため、消耗品サブセグメントが最大の市場シェアを占めています。

技術別では、HPV DNAの検出におけるPCRベースのアッセイの高い感度と特異性により、PCRサブセグメントが最大の市場シェアを占め、世界規模で子宮頸がんスクリーニングに好まれる技術となっています。

最終用途別では、病院・クリニックが最大の市場シェアを占めています。これらのヘルスケア環境は、子宮頸がんスクリーニングや診断プロセスを定期的に受ける人口の大部分にとって、主要なケアポイントとして機能しているからです。

地域別では、北米が現在ヒトパピローマウイルス検査市場で最大の市場シェアを占めています。アジア太平洋地域は、予測期間中にヒトパピローマウイルス検査市場で最も高い成長率を示すと予測されています。

ヒトパピローマウイルス検査市場で活発に活動している主要企業には、QIAGEN N.V.、F. Hoffmann-La Roche AG、Hologic, Inc.、Abbott Laboratories、Becton, Dickinson and Company（BD）、Thermo Fisher Scientific Inc.、Danaher Corporation（Cepheid）、bioMerieux S.A.、GenMark Diagnostics, Inc.（Rocheが買収）、Agilent Technologies, Inc.、Luminex Corporation（DiaSorin S.p.A.）などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のヒトパピローマウイルス検査市場の洞察

• 市場スナップショット
• ヒトパピローマウイルス検査市場力学
  • 促進要因と機会
    • 意識向上とスクリーニングプログラムの強化
    • 試験方法における技術的進歩
    • HPV感染率の増加
  • 抑制要因と課題
    • 認知度と検査率の低さ
• PESTEL分析
• ヒトパピローマウイルス検査市場の動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界のヒトパピローマウイルス検査市場：用途別

• 主な調査結果
• イントロダクション
• 子宮頸がん検診
• 膣がん検診

第6章 世界のヒトパピローマウイルス検査市場：製品別

• 主な調査結果
• イントロダクション
• 機器
• 消耗品
• サービス

第7章 世界のヒトパピローマウイルス検査市場：技術別

• 主な調査結果
• イントロダクション
• PCR
• 免疫診断
• その他の技術

第8章 世界のヒトパピローマウイルス検査市場：最終用途別

• 主な調査結果
• イントロダクション
• 病院と診療所
• ラボ
• その他

第9章 世界のヒトパピローマウイルス検査市場：地域別

• 主な調査結果
• イントロダクション
  • ヒトパピローマウイルス検査市場評価：地域別、2020～2034年
• 北米
  • 北米：用途別、2020～2034年
  • 北米：製品別、2020～2034年
  • 北米：技術別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：用途別、2020～2034年
  • 欧州：製品別、2020～2034年
  • 欧州：技術別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：用途別、2020～2034年
  • アジア太平洋地域：製品別、2020～2034年
  • アジア太平洋地域：技術別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：用途別、2020～2034年
  • 中東・アフリカ：製品別、2020～2034年
  • 中東・アフリカ：技術別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：用途別、2020～2034年
  • ラテンアメリカ：製品別、2020～2034年
  • ラテンアメリカ：技術別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company（BD）
• bioMerieux S.A.
• Danaher Corporation（Cepheid）
• F. Hoffmann-La Roche AG
• GenMark Diagnostics, Inc.（acquired by Roche）
• Hologic, Inc.
• Luminex Corporation（DiaSorin S.p.A.）
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.

List of Tables:

• Table 1 Global Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 2 Global Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 3 Global Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 4 Global Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 5 North America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 6 North America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 7 North America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 8 North America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 9 U.S.: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 10 U.S.: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 11 U.S.: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 12 U.S.: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 13 Canada: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 14 Canada: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 15 Canada: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 16 Canada: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 17 Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 18 Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 19 Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 20 Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 21 UK: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 22 UK: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 23 UK: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 24 UK: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 25 France: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 26 France: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 27 France: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 28 France: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 29 Germany: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 30 Germany: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 31 Germany: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 32 Germany: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 33 Italy: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 34 Italy: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 35 Italy: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 36 Italy: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 37 Spain: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 38 Spain: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 39 Spain: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 40 Spain: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 41 Netherlands: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 42 Netherlands: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 43 Netherlands: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 44 Netherlands: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 45 Russia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 46 Russia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 47 Russia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 48 Russia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 49 Rest of Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 50 Rest of Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 51 Rest of Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 52 Rest of Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 53 Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 54 Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 55 Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 56 Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 57 China: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 58 China: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 59 China: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 60 China: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 61 India: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 62 India: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 63 India: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 64 India: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 65 Malaysia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 66 Malaysia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 67 Malaysia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 68 Malaysia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 69 Japan: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 70 Japan: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 71 Japan: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 72 Japan: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 73 Indonesia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 74 Indonesia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 75 Indonesia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 76 Indonesia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 77 South Korea: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 78 South Korea: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 79 South Korea: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 80 South Korea: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 81 Australia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 82 Australia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 83 Australia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 84 Australia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 85 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 86 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 87 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 88 Rest of Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 89 Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 90 Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 91 Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 92 Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 93 Saudi Arabia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 94 Saudi Arabia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 95 Saudi Arabia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 96 Saudi Arabia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 97 UAE: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 98 UAE: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 99 UAE: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 100 UAE: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 101 Israel: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 102 Israel: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 103 Israel: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 104 Israel: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 105 South Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 106 South Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 107 South Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 108 South Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 109 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 110 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 111 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 112 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 113 Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 114 Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 115 Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 116 Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 117 Mexico: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 118 Mexico: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 119 Mexico: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 120 Mexico: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 121 Brazil: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 122 Brazil: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 123 Brazil: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 124 Brazil: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 125 Argentina: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 126 Argentina: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 127 Argentina: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 128 Argentina: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 129 Rest of Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 130 Rest of Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 131 Rest of Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 132 Rest of Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Global Human Papillomavirus Testing Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Application
• Figure 7. Global Human Papillomavirus Testing Market, by Application, 2024 & 2034 (USD Million)
• Figure 8. Market by Product
• Figure 9. Global Human Papillomavirus Testing Market, by Product, 2024 & 2034 (USD Million)
• Figure 10. Market by Technology
• Figure 11. Global Human Papillomavirus Testing Market, by Technology, 2024 & 2034 (USD Million)
• Figure 12. Market by End-Use
• Figure 13. Global Human Papillomavirus Testing Market, by End-Use, 2024 & 2034 (USD Million)

The global human papillomavirus (HPV) testing market size is expected to reach USD 5,547.92 Million by 2034, according to a new study by Polaris Market Research. The report "Human Papillomavirus Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Instruments, Consumables, Services), By Application, By Technology, By End-use, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The human papillomavirus (HPV) testing market encompasses the sale and distribution of diagnostic tests used to detect the presence of the HPV virus in biological samples. Primarily utilized in women's health, these tests play a critical role in screening for cervical cancer, as persistent infections with certain high-risk HPV genotypes are the primary cause of this disease. The market includes various testing methodologies, such as molecular tests that identify HPV DNA or RNA, as well as related instruments, consumables, and testing services offered by laboratories and healthcare providers.

The human papillomavirus testing market is experiencing significant growth, driven by increasing awareness of the link between HPV and cervical cancer, the implementation of national cervical cancer screening programs, and advancements in diagnostic technologies. A key market drive is the growing adoption of HPV testing as a primary screening tool or in conjunction with traditional HPV and Pap test. Furthermore, the development of more sensitive and specific HPV assays, along with the introduction of self-sampling options, is enhancing market penetration and accessibility. The market outlook remains positive, fueled by ongoing research, increasing market demand for early cancer detection, and supportive government initiatives promoting preventive healthcare.

Human Papillomavirus Testing Market Report Highlights:

By application, the cervical cancer screening subsegment currently holds the largest market share globally due to its established role in routine screening programs and the strong emphasis on early detection of precancerous lesions.

By product, the consumables subsegment accounts for the largest market share because of the recurring need for reagents, assay kits, and other disposable materials in the high volume of HPV testing procedures conducted worldwide for screening and diagnosis.

By technology, the PCR subsegment commands the largest market share owing to the high sensitivity and specificity of PCR-based assays in detecting HPV DNA, making it the preferred technology for cervical cancer screening on a global scale.

By end-use, the hospitals & clinics subsegment holds the largest market share as these healthcare settings serve as the primary points of care for a significant portion of the population undergoing routine cervical cancer screening and diagnostic processes.

By region, North America currently holds the largest market share in the human papillomavirus testing market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the human papillomavirus testing market over the forecast period.

Some of the major players actively operating in the human papillomavirus testing market include QIAGEN N.V., F. Hoffmann-La Roche AG, Hologic, Inc., Abbott Laboratories, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Danaher Corporation (Cepheid), bioMerieux S.A., GenMark Diagnostics, Inc. (acquired by Roche), Agilent Technologies, Inc., and Luminex Corporation (DiaSorin S.p.A.).

Polaris Market Research has segmented the Human Papillomavirus Testing market report based on application, product, technology, end-use, and region:

By Application Outlook (Revenue - USD Million, 2020-2034)

Cervical Cancer Screening

Vaginal Cancer Screening

By Product Outlook (Revenue - USD Million, 2020-2034)

Instruments

Consumables

Services

By Technology Outlook (Revenue - USD Million, 2020-2034)

PCR

Immunodiagnostics

Other Technologies

By End-Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Laboratories

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Human Papillomavirus Testing Market Insights

• 4.1. Human Papillomavirus Testing Market - Market Snapshot
• 4.2. Human Papillomavirus Testing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Awareness and Screening Programs
    • 4.2.1.2. Technological Advancements in Testing Methods
    • 4.2.1.3. Increasing Prevalence of HPV Infections
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Low awareness and screening rates
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Human Papillomavirus Testing Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Human Papillomavirus Testing Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• 5.3. Cervical Cancer Screening
  • 5.3.1. Global Human Papillomavirus Testing Market, by Cervical Cancer Screening, by Region, 2020-2034 (USD Million)
• 5.4. Vaginal Cancer Screening
  • 5.4.1. Global Human Papillomavirus Testing Market, by Vaginal Cancer Screening, by Region, 2020-2034 (USD Million)

6. Global Human Papillomavirus Testing Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• 6.3. Instruments
  • 6.3.1. Global Human Papillomavirus Testing Market, by Instruments, by Region, 2020-2034 (USD Million)
• 6.4. Consumables
  • 6.4.1. Global Human Papillomavirus Testing Market, by Consumables, by Region, 2020-2034 (USD Million)
• 6.5. Services
  • 6.5.1. Global Human Papillomavirus Testing Market, by Services, by Region, 2020-2034 (USD Million)

7. Global Human Papillomavirus Testing Market, by Technology

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• 7.3. PCR
  • 7.3.1. Global Human Papillomavirus Testing Market, by PCR, by Region, 2020-2034 (USD Million)
• 7.4. Immunodiagnostics
  • 7.4.1. Global Human Papillomavirus Testing Market, by Immunodiagnostics, by Region, 2020-2034 (USD Million)
• 7.5. Other Technologies
  • 7.5.1. Global Human Papillomavirus Testing Market, by Other Technologies, by Region, 2020-2034 (USD Million)

8. Global Human Papillomavirus Testing Market, by End-Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 8.3. Hospitals & Clinics
  • 8.3.1. Global Human Papillomavirus Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
• 8.4. Laboratories
  • 8.4.1. Global Human Papillomavirus Testing Market, by Laboratories, by Region, 2020-2034 (USD Million)
• 8.5. Others
  • 8.5.1. Global Human Papillomavirus Testing Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Human Papillomavirus Testing Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Human Papillomavirus Testing Market Assessment, By Geography, 2020-2034 (USD Million)
• 9.3. Human Papillomavirus Testing Market - North America
  • 9.3.1. North America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.3.2. North America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.3.3. North America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.3.4. North America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.3.5. Human Papillomavirus Testing Market - US
    • 9.3.5.1. US: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.3.5.2. US: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.3.5.3. US: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.5.4. US: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.3.6. Human Papillomavirus Testing Market - Canada
    • 9.3.6.1. Canada: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.3.6.2. Canada: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.3.6.3. Canada: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.6.4. Canada: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.4. Human Papillomavirus Testing Market - Europe
  • 9.4.1. Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.4.2. Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.4.3. Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.4.4. Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.5. Human Papillomavirus Testing Market - UK
    • 9.4.5.1. UK: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.5.2. UK: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.5.3. UK: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.5.4. UK: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.6. Human Papillomavirus Testing Market - France
    • 9.4.6.1. France: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.6.2. France: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.6.3. France: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.6.4. France: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.7. Human Papillomavirus Testing Market - Germany
    • 9.4.7.1. Germany: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.7.2. Germany: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.7.3. Germany: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.7.4. Germany: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.8. Human Papillomavirus Testing Market - Italy
    • 9.4.8.1. Italy: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.8.2. Italy: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.8.3. Italy: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.8.4. Italy: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.9. Human Papillomavirus Testing Market - Spain
    • 9.4.9.1. Spain: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.9.2. Spain: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.9.3. Spain: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.9.4. Spain: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.10. Human Papillomavirus Testing Market - Netherlands
    • 9.4.10.1. Netherlands: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.10.2. Netherlands: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.10.3. Netherlands: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.10.4. Netherlands: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.11. Human Papillomavirus Testing Market - Russia
    • 9.4.11.1. Russia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.11.2. Russia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.11.3. Russia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.11.4. Russia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.12. Human Papillomavirus Testing Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.12.2. Rest of Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.12.3. Rest of Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.12.4. Rest of Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.5. Human Papillomavirus Testing Market - Asia Pacific
  • 9.5.1. Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.5.2. Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.5.3. Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.5.4. Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.5. Human Papillomavirus Testing Market - China
    • 9.5.5.1. China: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.5.2. China: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.5.3. China: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.5.4. China: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.6. Human Papillomavirus Testing Market - India
    • 9.5.6.1. India: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.6.2. India: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.6.3. India: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.6.4. India: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.7. Human Papillomavirus Testing Market - Malaysia
    • 9.5.7.1. Malaysia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.7.2. Malaysia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.7.3. Malaysia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.7.4. Malaysia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.8. Human Papillomavirus Testing Market - Japan
    • 9.5.8.1. Japan: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.8.2. Japan: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.8.3. Japan: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.8.4. Japan: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.9. Human Papillomavirus Testing Market - Indonesia
    • 9.5.9.1. Indonesia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.9.2. Indonesia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.9.3. Indonesia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.9.4. Indonesia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.10. Human Papillomavirus Testing Market - South Korea
    • 9.5.10.1. South Korea: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.10.2. South Korea: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.10.3. South Korea: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.10.4. South Korea: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.11. Human Papillomavirus Testing Market - Australia
    • 9.5.11.1. Australia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.11.2. Australia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.11.3. Australia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.11.4. Australia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.12. Human Papillomavirus Testing Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.6. Human Papillomavirus Testing Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.6.2. Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.6.3. Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.6.4. Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.5. Human Papillomavirus Testing Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.5.2. Saudi Arabia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.5.3. Saudi Arabia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.5.4. Saudi Arabia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.6. Human Papillomavirus Testing Market - UAE
    • 9.6.6.1. UAE: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.6.2. UAE: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.6.3. UAE: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.6.4. UAE: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.7. Human Papillomavirus Testing Market - Israel
    • 9.6.7.1. Israel: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.7.2. Israel: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.7.3. Israel: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.7.4. Israel: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.8. Human Papillomavirus Testing Market - South Africa
    • 9.6.8.1. South Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.8.2. South Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.8.3. South Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.8.4. South Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.9. Human Papillomavirus Testing Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.7. Human Papillomavirus Testing Market - Latin America
  • 9.7.1. Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.7.2. Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.7.3. Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.7.4. Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.5. Human Papillomavirus Testing Market - Mexico
    • 9.7.5.1. Mexico: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.5.2. Mexico: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.5.3. Mexico: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.5.4. Mexico: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.6. Human Papillomavirus Testing Market - Brazil
    • 9.7.6.1. Brazil: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.6.2. Brazil: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.6.3. Brazil: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.6.4. Brazil: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.7. Human Papillomavirus Testing Market - Argentina
    • 9.7.7.1. Argentina: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.7.2. Argentina: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.7.3. Argentina: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.7.4. Argentina: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.8. Human Papillomavirus Testing Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.8.2. Rest of Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.8.3. Rest of Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.8.4. Rest of Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Agilent Technologies, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Becton, Dickinson and Company (BD)
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. bioMerieux S.A.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Danaher Corporation (Cepheid)
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. F. Hoffmann-La Roche AG
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. GenMark Diagnostics, Inc. (acquired by Roche)
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Hologic, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Luminex Corporation (DiaSorin S.p.A.)
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. QIAGEN N.V.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Thermo Fisher Scientific Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development